Healthcare >> CEO Interviews >> December 18, 2000

Lawrence Kenyon – Neopharm Inc (neol)

LAWRENCE A. KENYON joined NeoPharm, Inc., September 2000 as Chief Financial Officer. From October 1999 until September 2000 Mr. Kenyon was Senior Vice President of the Gabelli Mathers Fund, a regulated investment company. Prior to that, Mr. Kenyon held a variety of positions with Mathers and Company, Inc., an investment management firm, most recently serving as the Chief Financial officer for both Mathers and Company, Inc., and Mathers Fund, Inc., a regulated investment company. Mr. Kenyon is a Certified Public Accountant and received his BBA in Accounting from the University of Wisconsin-Whitewater in 1987. Profile
TWST: Could we start out with a history and a quick overview of

NeoPharm?

Mr. Kenyon: NeoPharm is a biopharmaceutical company engaged in the

research, development and commercialization of